Skip to main content
SpringerLink
Log in

Emergency treatment in glutaryl-CoA dehydrogenase deficiency

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: The history of glutaryl-CoA dehydrogenase deficiency is determined by acute encephalopathic crises that are precipitated by common febrile diseases, vaccinations or surgical interventions during infancy and early childhood. Such crises result in an irreversible destruction of the basal ganglia (in particular of the putamina), and consequently dystonia, dyskinesia and choreoathetosis. Secondary complications include feeding and speech problems, failure to thrive, recurrent aspiration, immobilization, severe motor deficits and early death. It is generally accepted that maintenance treatment based on dietary lysine or protein restriction and supplementation with carnitine (and riboflavin) is insufficient to prevent acute crises during intercurrent illnesses or conditions that enhance catabolic state. Consequently, outpatient and inpatient emergency therapies have been implemented. The present review describes a recommended approach to emergency therapy for this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Bjugstad KB, Goodman SI, Freed CR (2000) Age at symptomonset predicts severity o motor impairment and clinical outcome o glutaric acidemia type I. JPeiatr 137: 681-686.

    Google Scholar 

  • Bodamer OA, Hoffman GF, Visser GH, et al (1997) Assessment of energy expenditure in metabolic disorders. Eur J Pediatr 156(supplement 1): S24-28.

    Google Scholar 

  • Brismar J, Ozand PT (1995) CT and MR o the brain in glutaric aciduria type I:a review o 59 published cases and a report of 5 new patients. Am J Neuroradiol 16: 675-683.

    Google Scholar 

  • Busquets C, Merinero B, Christensen E, et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain:evidence o two groups o patients, genetically, and biochemically distinct. Pediatr Res 48: 315-322.

    Google Scholar 

  • D-A-CH (Deutsche Gesellschaft für Ern hrung, sterreichische Gesellscha t für Ern hrung, Schweizerische Gesellschaftür Ern hrungsforschung, Schweizerische Vereinigungür Ern hrung)(2000) Referenzwerte für die N hrstoüzufuhr. Frankfurt:Umschau/Braus.

  • Desai NK, Runge VM, Crisp DE, Crisp MB, Naul LG (2003) Magnetic resonance imaging o the brain in glutaric acidemia type I. Invest Radiol 38: 489-496.

    Google Scholar 

  • Elster AW (2004) Glutaric aciduria type I. Value of diüusion-weighted magnetic resonance imaging or diagnosing acute striatal necrosis. J Comput Assist Tomogr 28: 98-100.

    Google Scholar 

  • Feillet F, Bodamer OA, Dixon MA, Sequeira S, Leonard JV(2000) Restingenergy expenditure in disorders of propionate metabolism. JPeiatr 136: 659-663.

    Google Scholar 

  • Greenberg CR, Prasad AN, Dilling LA, et al (2002) Outcome of thefirst three years o a DNA-based neonatal screening program or glutaric acidemia type 1 in Manitoba and Northwestern Ontario, Canada. Mol Gen Metabol 75: 70-78.

    Google Scholar 

  • Hoffman GF, Athanassopoulos S, Burlina AB, et al (1996) Clinical course, early diagnosis, treatment, and prevention o disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27: 115-123.

    Google Scholar 

  • Institute o Medicine o the National Academy (2002) Dietary Reference Intakes (DRI) for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: Food and Nutrition Board; The National Academies Press.

    Google Scholar 

  • Koeller DM, Sauer S, Wajner M, et al (2004) Animal models for glutaryl-CoA dehydrogenase deficiency. JInheritMetabDis 27: 813-818.

    Google Scholar 

  • Kölker S, Schwab MA, Hörster F, et al (2003) Methylmalonic acid, a biochemical hallmark o methylmalonic acidurias but no inhibitor o mitochondrial respiratory chain. JBiolChem 278: 47388-47393.

    Google Scholar 

  • Kölker S, Koeller DM, Sauer S, et al (2004) Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. JInheritMetabDis 27: 805-812.

    Google Scholar 

  • Kyllerman M, Skjeldal O, Christensen E, et al (2004) Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol 8: 121-129.

    Google Scholar 

  • Monavari AA, Naughten ER (2000) Prevention o cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child 82: 67-70.

    Google Scholar 

  • Mühlhausen C, Hoffman GF, Strauss KA, et al (2004a) Maintenance treatment in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 885-892.

    Google Scholar 

  • Mühlhausen C, Ergün S, Strauss KA, et al (2004b) Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I. JInheritMetabDis 27: 829-834.

    Google Scholar 

  • Naughten ER, Mayne PD, Monavari AA, et al (2004) Glutaric aciduria type I:outcome in the Republic o Ireland. J Inherit Metab Dis 27: 917-920.

    Google Scholar 

  • Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiologicfindings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27: 869-876.

    Google Scholar 

  • Nyhan WL, Rice-Kelts M, Klein J, Barshop BA (1998) Treatment of acute crisis in maple syrup urine disease. Arch Pediatr A olesc Med 152: 593-598.

    Google Scholar 

  • Okun JG, Hörster F, Farkas LM, et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and tricarboxylic acid cycle, and synergistically acting excitotoxicity. JBiolChem 277: 14674-14680.

    Google Scholar 

  • Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffman GF (2002) Emergency manage-ment o inherited metabolic diseases. JInheritMetabDis 25: 531-546.

    Google Scholar 

  • Strauss KA, Puüenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1:natural history of 77 patients. Am J Med Genet 121C: 38-52.

    Google Scholar 

  • Twomey EL, Naughten ER, Donogue VB, Ryan S (2003) Neuroimagingfindings in glutaric aciduria type 1. Pediatr Radiol 33: 823-830.

    Google Scholar 

  • Varadkar S, Surtees R (2004) Glutaric aciduria type I and kynurenine pathway metabolites:a modified hypothesis. J Inherit Metab Dis 27: 835-842.

    Google Scholar 

  • Wajner M, Kölker S, Souza DO, Hoffman GF, de Mello CF (2004) Modulation o glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. JInheritMetabDis 27: 825-828.

    Google Scholar 

  • Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Maple syrup urine disease therapeutic use of insulin in catabolic states. Eur J Pediatr 139: 172-175.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Children's Hospital, Department of General Pediatrics, Division of Metabolic and Endocrine Diseases, Heidelberg, Germany

    S. KÖlker, M. Lindner, E. Müller & G. F. Hoffmann

  2. Departments of Pediatrics and Child Health and Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada

    C. R. Greenberg

  3. The National Centre of Inherited Metabolic Disorders and Department of Clinical Chemistry, Children's University Hospital, Temple Street, Dublin, Ireland

    E. R. Naughten

Authors
  1. S. KÖlker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. R. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Lindner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. R. Naughten
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. F. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. F. Hoffmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

KÖlker, S., Greenberg, C.R., Lindner, M. et al. Emergency treatment in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27, 893–902 (2004). https://doi.org/10.1023/B:BOLI.0000045774.51260.ea

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000045774.51260.ea

Keywords

Search

Navigation